Thoroughbred Financial Services LLC Has $76,000 Stock Holdings in CEL-SCI Co. (NYSE:CVM)

Thoroughbred Financial Services LLC increased its stake in shares of CEL-SCI Co. (NYSE:CVM) by 40.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 191,661 shares of the company’s stock after buying an additional 54,900 shares during the quarter. Thoroughbred Financial Services LLC’s holdings in CEL-SCI were worth $76,000 at the end of the most recent reporting period.

Separately, Geode Capital Management LLC raised its position in CEL-SCI by 9.6% in the 3rd quarter. Geode Capital Management LLC now owns 612,861 shares of the company’s stock valued at $650,000 after purchasing an additional 53,879 shares during the last quarter. 12.08% of the stock is currently owned by institutional investors and hedge funds.

CEL-SCI Stock Down 3.5 %

Shares of NYSE CVM opened at $0.21 on Tuesday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.09 and a current ratio of 1.07. CEL-SCI Co. has a 52-week low of $0.18 and a 52-week high of $2.39. The firm has a 50 day moving average price of $0.33 and a 200 day moving average price of $0.58. The stock has a market cap of $16.71 million, a P/E ratio of -0.43 and a beta of 0.95.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on CEL-SCI in a research report on Sunday. They issued a “sell” rating on the stock.

About CEL-SCI

CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers.